Clinical Trial Update: Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations

View source ↗

Summary

This completed clinical trial examined nasal epithelial cell and blood lymphocyte biomarkers in cystic fibrosis and CF pulmonary_exacerbations. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Cystic Fibrosis | Status: COMPLETED | Results posted: 2017-02-15